EMBRACA: Efficacy and safety of talazoparib or physician's choice of therapy in patients with advanced breast cancer and a germline BRCA1/2 mutation: A regional analysis
Dokumenttyp:
Meeting Abstract
Autor(en):
Mina, L.; Lee, K-H; Goncalves, A.; Woodward, N.; Hurvitz, S. A.; Diab, S.; Yerushalmi, R.; Goodwin, A.; Moreira Costa Zorzetto, M.; Kim, S-B; Czibere, A.; Tudor, I. C.; Gauthier, E.; Litton, J. K.; Ettl, J.